RoC Skincare pairs identical-twin retinol study with Oura Ring data

The brand is recruiting 30 pairs of US women aged 40 and older for a 12-week phase that combines wearable biometrics with clinical skin grading.

RoC Skincare is testing its Patented Clinical Retinol on adult female identical twins, pairing lifestyle biometric data gathered from Oura Rings with conventional clinical skin measurements. The company frames the work as a pilot study built to establish whether identical twins are a useful model for identifying what drives visible skin aging.

Art Pellegrino, chief scientific officer at RoC Skincare, told Personal Care Insights that when two people start from the same genetic blueprint, differences between them are harder to attribute to genetics, which makes it easier to see what the retinol is doing on the skin. He said the pilot was mainly about proving the model, and that the answer was yes.

Twins as a natural control

Because identical twins share DNA and much of their early environment, researchers can more confidently identify lifestyle factors or products as the explanation for differences in how their skin ages, Pellegrino said. He described identical twins as about as close as it gets to a natural control: if their skin ages differently, lifestyle and environment become the likelier explanation.

Pilot findings and the next phase

According to Pellegrino, twins in the placebo group showed similar or worse signs of aging at the end of the study, while twins in the treatment group improved by 20% or more in just four weeks.

He said the pilot did not try to measure how much skin aging comes from genes versus lifestyle, and that this is what the expanded study is for. RoC is recruiting 30 pairs of adult female identical twins aged 40 and older living in the US for that phase, in which participants will use the regimen for 12 weeks. Pellegrino said the focused group is intended to yield cleaner data to build on, and that the work is one stage in a longer research program on skin span, or how long skin keeps looking its best. RoC expects results from the twin study by mid-2027.

Wearables and lifestyle tracking

Throughout the study, twins are asked to wear an Oura Ring, a wearable that tracks health and wellness metrics through the day and captures variation in biometric data such as sleep, stress, heart rate, heart rate variability and temperature trends. Pellegrino said wearables are opening an opportunity across the industry to factor in how people live when recommending skin care.

Because RoC cannot guarantee that twins share external influences such as sun exposure or diet, it is recruiting twins with similar levels of environmental damage wherever possible and tracking lifestyle factors closely. With genetics held constant by the twin design and lifestyle tracked directly by the ring, the brand expects to quantify external stressors and their effect on each participant's skin. Pellegrino gave examples: whether weeks of poor sleep line up with lower hydration readings, or whether the twin with lower stress levels sees fine lines improve faster. RoC is also interested in the reverse question, whether participants who see visible improvement in their skin feel less stressed.

Clinical measures

RoC's standard clinical skin measures evaluate changes in the signs of skin aging through expert grading, digital photography, corneometer readings and subject self-assessment. Pellegrino said what the company learns will shape how it develops products for skin longevity and how it designs clinical studies going forward.

SA

Solveig Andresen

Solveig Andresen is a cosmetic safety and packaging editor covering facial mask sheets, beauty disposables, skincare formulations, and color cosmetics. Her reviews examine ISO 22716:2007 as a manufacturing GMP guide, ISO 11930:2019 where antimicrobial protection is assessed, EU PIF, CPSR, and INCI duties, and United States MoCRA obligations, with mask sheet gsm, serum loading in g/g, and container compatibility. She writes for regulatory affairs, quality, packaging, and product development teams comparing label content, supplier evidence, and test scope.